Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Raymond

Showing results (321-330 of 345) with videos related to

Pageof 35
Sort By:
Nature Biotechnology|December 21, 2004
Microfluidic sorting of mammalian cells by optical force switchingMark M Wang, Eugene Tu, Daniel E Raymond, et al.
The Journal of Invasive Cardiology|April 10, 2008
Efficacy of a novel procedure sheath and closure device during diagnostic catheterization: the multicenter randomized clinical trial of the FISH deviceAnthony A Bavry, Russell E Raymond, Deepak L Bhatt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2002
Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor typesJ Baselga, D Rischin, M Ranson, et al.
Journal of the American College of Cardiology|May 14, 2013
Cause of death within 30 days of percutaneous coronary intervention in an era of mandatory outcome reportingBhuvnesh Aggarwal, Stephen G Ellis, A Michael Lincoff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignanciesJ P Delord, E Raymond, M Chaouche, et al.
The American Journal of Cardiology|March 18, 1999
Comparison of slow oscillating versus fast balloon inflation strategies for coronary angioplastyJ C Blankenship, M W Krucoff, S W Werns, et al.
The Annals of Thoracic Surgery|September 2, 2000
Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTingA M Lincoff, L A LeNarz, G J Despotis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Population pharmacokinetics of the novel anticancer agent E7070 during four phase I studies: model building and validationCh Van Kesteren, R A A Mathôt, E Raymond, et al.
Circulation|July 1, 1997
First chronic platelet glycoprotein IIb/IIIa integrin blockade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventionsC Simpfendorfer, K Kottke-Marchant, M Lowrie, et al.
Nature Biotechnology|November 17, 2020
A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cellsGiang N Nguyen, John K Everett, Samita Kafle, et al.
Pageof 35

Showing results (321-330 of 345) with videos related to

Sort By:
Pageof 35
Nature Biotechnology|December 21, 2004
Microfluidic sorting of mammalian cells by optical force switchingMark M Wang, Eugene Tu, Daniel E Raymond, et al.
The Journal of Invasive Cardiology|April 10, 2008
Efficacy of a novel procedure sheath and closure device during diagnostic catheterization: the multicenter randomized clinical trial of the FISH deviceAnthony A Bavry, Russell E Raymond, Deepak L Bhatt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2002
Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor typesJ Baselga, D Rischin, M Ranson, et al.
Journal of the American College of Cardiology|May 14, 2013
Cause of death within 30 days of percutaneous coronary intervention in an era of mandatory outcome reportingBhuvnesh Aggarwal, Stephen G Ellis, A Michael Lincoff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignanciesJ P Delord, E Raymond, M Chaouche, et al.
The American Journal of Cardiology|March 18, 1999
Comparison of slow oscillating versus fast balloon inflation strategies for coronary angioplastyJ C Blankenship, M W Krucoff, S W Werns, et al.
The Annals of Thoracic Surgery|September 2, 2000
Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTingA M Lincoff, L A LeNarz, G J Despotis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Population pharmacokinetics of the novel anticancer agent E7070 during four phase I studies: model building and validationCh Van Kesteren, R A A Mathôt, E Raymond, et al.
Circulation|July 1, 1997
First chronic platelet glycoprotein IIb/IIIa integrin blockade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventionsC Simpfendorfer, K Kottke-Marchant, M Lowrie, et al.
Nature Biotechnology|November 17, 2020
A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cellsGiang N Nguyen, John K Everett, Samita Kafle, et al.
Pageof 35